Examworks Group Stock Price Up 4.3% on Analyst Upgrade (EXAM)
Examworks Group (NASDAQ:EXAM) shares shot up 4.3% on Monday after Credit Suisse raised their price target on the stock from $37.00 to $41.00, AR Network reports. Credit Suisse currently has an outperform rating on the stock. Examworks Group traded as high as $37.39 and last traded at $37.28, with a volume of 278,763 shares changing hands. The stock had previously closed at $35.73.
Separately, analysts at Needham & Company LLC raised their price target on shares of Examworks Group from $33.00 to $39.00 in a research note on Wednesday, February 26th.
The stock’s 50-day moving average is $35.00 and its 200-day moving average is $30.39. The company’s market cap is $1.385 billion.
Examworks Group (NASDAQ:EXAM) last announced its earnings results on Tuesday, February 25th. The company reported ($0.08) earnings per share for the quarter, missing the analysts’ consensus estimate of ($0.06) by $0.02. The company had revenue of $158.80 million for the quarter, compared to the consensus estimate of $151.51 million. On average, analysts predict that Examworks Group will post $0.14 earnings per share for the current fiscal year.
ExamWorks Group, Inc (NASDAQ:EXAM) is a provider of independent medical examinations (IMEs), peer and bill reviews, and related services, referred to as IME services or the IME industry.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.